Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2017

Open Access 01-12-2017 | Review

Personalised fluid resuscitation in the ICU: still a fluid concept?

Author: Frank van Haren

Published in: Critical Care | Special Issue 3/2017

Login to get access

Abstract

The administration of intravenous fluid to critically ill patients is one of the most common, but also one of the most fiercely debated, interventions in intensive care medicine. Even though many thousands of patients have been enrolled in large trials of alternative fluid strategies, consensus remains elusive and practice is widely variable. Critically ill patients are significantly heterogeneous, making a one size fits all approach unlikely to be successful.
New data from basic, animal, and clinical research suggest that fluid resuscitation could be associated with significant harm. There are several important limitations and concerns regarding fluid bolus therapy as it is currently being used in clinical practice. These include, but are not limited to: the lack of an agreed definition; limited and short-lived physiological effects; no evidence of an effect on relevant patient outcomes; and the potential to contribute to fluid overload, specifically when fluid responsiveness is not assessed and when targets and safety limits are not used.
Fluid administration in critically ill patients requires clinicians to integrate abnormal physiological parameters into a clinical decision-making model that also incorporates the likely diagnosis and the likely risk or benefit in the specific patient’s context. Personalised fluid resuscitation requires careful attention to the mnemonic CIT TAIT: context, indication, targets, timing, amount of fluid, infusion strategy, and type of fluid.
The research agenda should focus on experimental and clinical studies to: improve our understanding of the physiological effects of fluid infusion, e.g. on the glycocalyx; evaluate new types of fluids; evaluate novel fluid minimisation protocols; study the effects of a no-fluid strategy for selected patients and scenarios; and compare fluid therapy with other interventions. The adaptive platform trial design may provide us with the tools to evaluate these types of interventions in the intrinsically heterogeneous intensive care unit population, accounting for the explicit assumption that treatment effects may be heterogeneous.
Literature
1.
Council EU. Council conclusions on personalised medicine for patients (2015/C 421/03). Off J Eur Union. 2015;58(C 421):2–6.
2.
Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361–80.CrossRefPubMed
3.
4.
Vincent JL. Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? NO. Intensive Care Med. 2016;42(11):1778–80.CrossRefPubMed
5.
Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2016;125(1):46–61.CrossRefPubMed
6.
Stoneking LR, Winkler JP, DeLuca LA, Stolz U, Stutz A, Luman JC, Gaub M, Wolk DM, Fiorello AB, Denninghoff KR. Physician documentation of sepsis syndrome is associated with more aggressive treatment. West J Emerg Med. 2015;16(3):401–7.CrossRefPubMedPubMedCentral
7.
Rhee C, Kadri SS, Danner RL, Suffredini AF, Massaro AF, Kitch BT, Lee G, Klompas M. Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care. 2016;20:89.CrossRefPubMedPubMedCentral
8.
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.CrossRefPubMed
9.
van Haren FM, Sleigh JW, Pickkers P, Van der Hoeven JG. Gastrointestinal perfusion in septic shock. Anaesth Intensive Care. 2007;35(5):679–94.PubMed
10.
Levy B, Gawalkiewicz P, Vallet B, Briancon S, Nace L, Bollaert PE. Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med. 2003;31(2):474–80.CrossRefPubMed
11.
Egal M, Erler NS, de Geus HR, van Bommel J, Groeneveld AB. Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg. 2016;122(1):173–85.CrossRefPubMed
12.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.CrossRefPubMed
13.
Glassford NJ, Jones SL, Martensson J, Eastwoods GM, Bailey M, Cross AM, Taylor DM, Bellomo R. Characteristics and expectations of fluid bolus therapy: a bi-national survey of acute care physicians. Anaesth Intensive Care. 2015;43(6):750–6.PubMed
14.
Glassford NJ, Martensson J, Eastwood GM, Jones SL, Tanaka A, Wilkman E, Bailey M, Bellomo R, Global Observational Evaluations in the ICU (GLOBE-ICU) investigators. Defining the characteristics and expectations of fluid bolus therapy: a worldwide perspective. J Crit Care. 2016;35:126–32.CrossRefPubMed
15.
Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, Della Rocca G, Aldecoa C, Artigas A, Jog S, et al. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med. 2015;41(9):1529–37.CrossRefPubMedPubMedCentral
16.
Glassford NJ, Eastwood GM, Bellomo R. Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data. Crit Care. 2014;18(6):696.CrossRefPubMedPubMedCentral
17.
van Haren FM, Sleigh J, Boerma EC, La Pine M, Bahr M, Pickkers P, van der Hoeven JG. Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study. Shock. 2012;37(3):268–75.CrossRefPubMed
18.
Ho L, Lau L, Churilov L, Riedel B, McNicol L, Hahn RG, Weinberg L. Comparative evaluation of crystalloid resuscitation rate in a human model of compensated haemorrhagic shock. Shock. 2016;46(2):149–57.CrossRefPubMedPubMedCentral
19.
Nunes TS, Ladeira RT, Bafi AT, de Azevedo LC, Machado FR, Freitas FG. Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation. Ann Intensive Care. 2014;4:25.CrossRefPubMedPubMedCentral
20.
Bihari S, Prakash S, Bersten AD. Post resusicitation fluid boluses in severe sepsis or septic shock: prevalence and efficacy (price study). Shock. 2013;40(1):28–34.CrossRefPubMed
21.
Lammi MR, Aiello B, Burg GT, Rehman T, Douglas IS, Wheeler AP, deBoisblanc BP, National Institutes of Health NHL. Response to fluid boluses in the fluid and catheter treatment trial. Chest. 2015;148(4):919–26.CrossRefPubMedPubMedCentral
22.
Bihari S, Teubner DJ, Prakash S, Beatty T, Morphett M, Bellomo R, Bersten A. Fluid bolus therapy in emergency department patients: indications and physiological changes. Emerg Med Australas. 2016;28(5):531–7.CrossRefPubMed
23.
Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015;41(9):1549–60.CrossRefPubMed
24.
Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest. 2002;121(6):2000–8.CrossRefPubMed
25.
Michard F, Biais M. Rational fluid management: dissecting facts from fiction. Br J Anaesth. 2012;108(3):369–71.CrossRefPubMed
26.
Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, Teboul JL. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34(5):1402–7.CrossRefPubMed
27.
28.
Sadaka F, Juarez M, Naydenov S, O’Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intensive Care Med. 2014;29(4):213–7.CrossRefPubMed
29.
Smith SH, Perner A. Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care. 2012;16(3):R76.CrossRefPubMedPubMedCentral
30.
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259–65.CrossRefPubMed
31.
Samoni S, Vigo V, Resendiz LI, Villa G, De Rosa S, Nalesso F, Ferrari F, Meola M, Brendolan A, Malacarne P, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95.CrossRefPubMedPubMedCentral
32.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, DeBoisblanc B, Connors Jr AF, Hite RD, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75.CrossRef
33.
Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483–95.CrossRefPubMed
34.
Southall D, Samuels M. Treating the wrong children with fluids will cause harm: response to ‘mortality after fluid bolus in African children with severe infection’. Arch Dis Child. 2011;96(10):905–6.CrossRefPubMed
35.
Ford S, Visram A. Mortality after fluid bolus in African children with sepsis. N Engl J Med. 2011;365(14):1348.CrossRefPubMed
36.
Myburgh J, Finfer S. Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Med. 2013;11(1):1.CrossRef
37.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–21.CrossRefPubMed
38.
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, Investigators SS. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–56.CrossRefPubMed
39.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901–11.CrossRefPubMed
40.
Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14(5):R185.CrossRefPubMedPubMedCentral
41.
Hammond NE, Taylor C, Saxena M, Liu B, Finfer S, Glass P, Seppelt I, Willenberg L, Myburgh J. Resuscitation fluid use in Australian and New Zealand intensive care units between 2007 and 2013. Intensive Care Med. 2015;41(9):1611–9.CrossRefPubMed
42.
Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93(4):811–6.CrossRefPubMed
43.
Moviat M, van Haren F, van der Hoeven H. Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care. 2003;7(3):R41–5.CrossRefPubMedPubMedCentral
44.
Morgan TJ. The meaning of acid-base abnormalities in the intensive care unit: part III—effects of fluid administration. Crit Care. 2005;9(2):204–11.CrossRefPubMed
45.
Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24.CrossRefPubMed
46.
Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2014;259(5):881–7.CrossRefPubMed
47.
Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002;30(2):300–5.CrossRefPubMed
48.
Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–72.CrossRefPubMed
49.
Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314(16):1701–10.CrossRefPubMed
50.
Vincent JL, De Backer D. Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed? Crit Care. 2016;20(1):250.CrossRefPubMedPubMedCentral
51.
Marik P, Bellomo R. A rational approach to fluid therapy in sepsis. Br J Anaesth. 2016;116(3):339–49.CrossRefPubMed
52.
Chen C, Kollef MH. Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest. 2015;148(6):1462–9.CrossRefPubMed
53.
Henrich M, Gruss M, Weigand MA. Sepsis-induced degradation of endothelial glycocalix. ScientificWorldJournal. 2010;10:917–23.CrossRefPubMed
54.
Berg S, Golster M, Lisander B. Albumin extravasation and tissue washout of hyaluronan after plasma volume expansion with crystalloid or hypooncotic colloid solutions. Acta Anaesthesiol Scand. 2002;46(2):166–72.CrossRefPubMed
55.
Berg S, Engman A, Hesselvik JF, Laurent TC. Crystalloid infusion increases plasma hyaluronan. Crit Care Med. 1994;22(10):1563–7.CrossRefPubMed
56.
Chappell D, Bruegger D, Potzel J, Jacob M, Brettner F, Vogeser M, Conzen P, Becker BF, Rehm M. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538.CrossRefPubMedPubMedCentral
57.
Hamzaoui O, Georger JF, Monnet X, Ksouri H, Maizel J, Richard C, Teboul JL. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010;14(4):R142.CrossRefPubMedPubMedCentral
58.
van Haren FM, Sleigh J, Cursons R, La Pine M, Pickkers P, van der Hoeven JG. The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study. Ann Intensive Care. 2011;1(1):44.CrossRefPubMedPubMedCentral
59.
van Haren HMP. The use of hypertonic solutions in sepsis. Trends Anaesthesia Crit Care. 2013;3(1):37–41.CrossRef
60.
Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA. 2015;313(16):1619–20.CrossRefPubMed
61.
Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials. 2016;13(3):358–66.CrossRefPubMed
Metadata
Title
Personalised fluid resuscitation in the ICU: still a fluid concept?
Author
Frank van Haren
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 3/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-017-1909-5

Other articles of this Special Issue 3/2017

Critical Care 3/2017 Go to the issue

Review

Time-sensitive therapeutics

Review

Seven unconfirmed ideas to improve future ICU practice

Review

Regional physiology of ARDS

Review

The bloody mess of red blood cell transfusion

Review

Personalized physiological medicine

Review

Detailing the cardiovascular profile in shock patients